Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sejal S. Kuthiala"'
Publikováno v:
Bone Marrow Transplantation. 37:219-221
We evaluated the number and characteristics of randomized controlled trials (RCTs) addressing hematopoietic stem cell transplantation (HSCT) for patients with hematological malignancies, comparing the productivity of US and Europe. A MEDLINE search w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9f58781ce0fa2a1c1747fc6aad2513
https://doi.org/10.1038/sj.bmt.1705230
https://doi.org/10.1038/sj.bmt.1705230
Publikováno v:
Blood. 114:1533-1533
Abstract 1533 Poster Board I-556 Hydroxyurea (HU) is an S-phase specific cytotoxic agent (pregnancy category D), approved for use in sickle cell disease (SCD) primarily due to its ability to augment production of fetal hemoglobin (HbF), which has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47569ee1bec2b84c59358507f5fb536c
https://doi.org/10.1182/blood.v114.22.1533.1533
https://doi.org/10.1182/blood.v114.22.1533.1533
Publikováno v:
Blood. 104:229-229
Introduction: Evidence-based medicine defines standard therapies primarily from Phase III randomized controlled trials (RCT), when available. In this report we examined trends in ther number and characteristics of phase III RCT addressing the managem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8426e9bb20158a4d566fe8b0a1615a6e
https://doi.org/10.1182/blood.v104.11.229.229
https://doi.org/10.1182/blood.v104.11.229.229